RxDoctor Payments Data

Thomas Rehm, DPM

Podiatrist · Asheville, NCNPI 1447213921

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,834 of the $2,904 with a category attached, or 63.2%. 23 manufacturers reported payments, led by Peerless Surgical Inc. at 37.9% of the total. Reporting peaked in 2019 at $1,645 and has fallen 78.5% since, to $353 in 2025.

$2,904in general payments, 2019–2025

Across 52 payments — averaging $55.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Peerless Surgical Inc.$1K
  • Treace Medical Concepts, Inc.$315
  • Smith+Nephew$246
  • Osiris Therapeutics Inc.$241
  • Linvatec Corporation$164
  • Inari Medical, Inc.$145
  • plus $692 from 17 others

What the payments were for

  • Food & beverage$1,83463%
  • Education$1,07037%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,904 in reported general payments places this provider in the 60th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$164,217
Medicare patients
629
Services billed
2,504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib236$4,740
Fluconazole303$4,397
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha176$2,232
Fluorouracil20$1,365
Colchicine39$1,160
Pregabalin140$868
Nystatin56$720
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip20$599
Doxycycline Hyclate74$503
Mupirocin65$496
Methylprednisolone91$478
Meloxicam124$348
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$292
Gabapentin42$244
Ammonium Lactate11$226

Paid to pharmacies, not to this prescriber.

Other podiatrist in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →